thrombolysis in myocardial infarction


Also found in: Acronyms, Wikipedia.

thrombolysis in myocardial infarction

,

TIMI

A large series of studies on the use of thrombolytic drugs and percutaneous coronary intervention in patients with acute coronary syndromes. The studies are sponsored by the Thrombolysis in Myocardial Infarction Study Group (TIMI Study Group). Website: www.timi.org
References in periodicals archive ?
CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; LV-EF, left ventricular ejection fraction; TRI, the thrombolysis in myocardial infarction risk index.
The Thrombolysis in Myocardial Infarction (TIMI) Study Group is an investigative team that has been at the forefront of clinical research in acute coronary syndromes over the past two decades.
Thrombolysis in myocardial infarction (TIMI) blood flow grades are used to evaluate the quality of coronary flow during coronary angiography12.
The Thrombolysis in Myocardial Infarction (TIMI) risk score (TRS) was calculated from the initial clinical history, electrocardiogram (ECG), and laboratory values collected on admission.
Data collection: The prospective information on variables including age, gender, history of diabetes, hypertension, hyperlipidaemia, Smoking, angiographic and procedural details (number of vessels, segment of vessel, use of aspiration catheter, clot retrieval, use of stents, GP IIb IIIa inhibitors, Thrombolysis in Myocardial Infarction (TIMI) flow, and Tissue Myocardial perfusion (TMP) grade and Electrocardiogram (ECG) findings were recorded.
The first, from the Thrombolysis in Myocardial Infarction (TIMI) group (9), evaluated only the initial samples of patients enrolled in 1 of 2 randomized therapy trials.
The Thrombolysis in Myocardial Infarction (TIMI) risk score is widely used but has not performed consistently for low-risk populations.
Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial).
The quantitative scale like Thrombolysis in Myocardial Infarction (TIMI) grading system that was used to find the flow in the culprit artery as grade3 flow being the goal of thrombolytic therapy was not possible due to limited availability and non affordability of patients.